Fingolimod Active Not Recruiting Phase 3 Trials for Relapsing Forms of Multiple Sclerosis Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01201356Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis